Refractory coeliac disease: remission with infliximab and immunomodulators. [electronic resource]
- European journal of gastroenterology & hepatology Jun 2005
- 667-9 p. digital
Publication Type: Case Reports; Journal Article; Review
0954-691X
10.1097/00042737-200506000-00012 doi
Aged Antibodies, Monoclonal--therapeutic use Celiac Disease--drug therapy Drug Therapy, Combination Gastrointestinal Agents--therapeutic use Humans Infliximab Male Prednisolone--therapeutic use Remission Induction Tumor Necrosis Factor-alpha--antagonists & inhibitors